Hits and misses in targeting pediatric cancers.
作者信息
Bernstein Mark L
机构信息
IWK Health Centre Halifax, Nova Scotia, Canada.
出版信息
Pediatr Blood Cancer. 2009 Jul;52(7):751-2. doi: 10.1002/pbc.21937.
PMID:19185009
Abstract
摘要
相似文献
1
Hits and misses in targeting pediatric cancers.
Pediatr Blood Cancer. 2009 Jul;52(7):751-2. doi: 10.1002/pbc.21937.
2
[Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):875-7.
3
[Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear].
Lakartidningen. 2009;106(50-51):3424-9.
4
Current management of GISTs.
Clin Adv Hematol Oncol. 2010 May;8(5):334.
5
Sunitinib for imatinib-resistant GIST.
Lancet. 2006 Oct 14;368(9544):1303-4. doi: 10.1016/S0140-6736(06)69489-0.
6
[Gastrointestinal stromal tumor (GIST)--tyrosine kinase inhibitors].
Nihon Rinsho. 2012 Nov;70 Suppl 8:452-6.
7
[Resistance and treatment strategy of gastrointestinal stromal tumor target therapy].
Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Mar;15(3):309-12.
8
Recent advances in therapy for gastrointestinal stromal tumors.
Curr Oncol Rep. 2007 May;9(3):165-9. doi: 10.1007/s11912-007-0017-0.
9
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
Pediatr Blood Cancer. 2009 Jul;52(7):767-71. doi: 10.1002/pbc.21909.
10
Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?
Oncology (Williston Park). 2009 Jan;23(1):65-6.
Zotero 插件